NRX Pharmaceuticals (STU:B1Q) Price-to-Operating-Cash-Flow : (As of Jun. 21, 2024)

View and export this data going back to 2020. Start your Free Trial

What is NRX Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-06-21), NRX Pharmaceuticals's share price is €4.88. NRX Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.27. Hence, NRX Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for NRX Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 4 years, NRX Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 58.76. The lowest was 0.00. And the median was 0.00.

STU:B1Q's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.45
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

NRX Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.40. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.27.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -62.90% per year.

During the past 4 years, NRX Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was -62.90% per year. The lowest was -62.90% per year. And the median was -62.90% per year.

NRX Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NRX Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NRX Pharmaceuticals Price-to-Operating-Cash-Flow Chart

NRX Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

NRX Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of NRX Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, NRX Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NRX Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NRX Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NRX Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

NRX Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

NRX Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	4.88	/	-2.272
	=

NRX Pharmaceuticals's Share Price of today is €4.88.
NRX Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.27.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

NRX Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NRX Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

NRX Pharmaceuticals (STU:B1Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NRX Pharmaceuticals Inc (STU:B1Q) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

NRXP:USA

Address

1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801

Website

https://nrxpharma.com

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.

NRX Pharmaceuticals (STU:B1Q) Headlines

No Headlines